Dr Reddys Laboratories (RDY) Amortization of Goodwill (2009 - 2022)

Dr Reddys Laboratories (RDY) posted quarterly Amortization of Goodwill of $7.0 million for Q4 2022, up 1300.0% on a QoQ basis from $500000.0 in Q3 2017.

Dr Reddys Laboratories (RDY) Amortization of Goodwill (2009 - 2022) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported Amortization of Goodwill for 7 consecutive years, with $7.0 million the latest figure, recorded in Q4 2022.

  • Quarterly Amortization of Goodwill changed N/A year-over-year to $7.0 million in Q4 2022, while the trailing twelve-month figure through Mar 2023 was $7.5 million (changed N/A YoY) and the FY2013 annual result came in at $181.0 million, changed N/A from the prior year.
  • Amortization of Goodwill rose to $7.0 million in Q4 2022 per RDY's latest filing, from $500000.0 in the prior quarter.
  • Over the last five years, Amortization of Goodwill for RDY reached as high as $7.0 million in Q4 2022 and fell as low as $7.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Dr Reddys Laboratories 9.82 Bn 9.66 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2022 7.00 Mn
Dec 31, 2022 7.00 Mn
Sep 30, 2017 500,000.00
Sep 30, 2017 500,000.00
Dec 31, 2015 1.40
Dec 31, 2015 1.40
Sep 30, 2015 8.00
Sep 30, 2015 8.00
Jun 30, 2013 181.00 Mn
Jun 30, 2013 181.00 Mn
Dec 31, 2012 19.00
Dec 31, 2012 19.00
Jun 30, 2012 688.00 Mn
Jun 30, 2012 688.00 Mn
Sep 30, 2010 115.00 Mn
Sep 30, 2010 115.00 Mn
Mar 31, 2010 5.04 Bn
Mar 31, 2010 5.04 Bn
Dec 31, 2009 242.00 Mn
Dec 31, 2009 242.00 Mn